Neuromodulation for Substance Use Disorders.
This talk will review the current evidence on neuromodulation for substance use disorders.
Objectives:
- Name 3 forms of neuromodulation.
- Name an FDA-approved indication for rTMS.
- Describe the evidence for neuromodulation for substance use disorders.
Heather Ward, CV
Dr. Heather Burrell Ward attended Duke University School of Medicine and completed psychiatry residency training at Brigham & Women’s Hospital – Harvard Medical School in the Research Track. Dr. Ward completed fellowship training in Behavioral Neurology and neuromodulation at the Berenson-Allen Center for Noninvasive Brain Stimulation at Beth Israel Deaconess Medical Center and Harvard Medical School. At Vanderbilt, Dr. Ward is Director of Neuromodulation Research, where she oversees and facilitates research using a variety of neuromodulation interventions (rTMS, ECT, DBS). In her lab, Dr. Ward uses rTMS and neuroimaging to understand and treat the brain-circuit basis of substance use and psychotic disorders. In a NIDA-funded K23 Career Development Award, Dr. Ward is using individualized, network-targeted TMS interventions for nicotine dependence in schizophrenia.
Education
2007-2011 BA, Chemistry, Williams College, Williamstown, MA
2013-2017 MD, Duke University School of Medicine, Durham, NC
Postdoctoral Training:
2017-2021 Resident in Psychiatry, Research Track, Brigham & Women’s Hospital,
Harvard Medical School, Boston, MA
2020-2021 Chief Resident for Research, Brigham & Women’s Hospital,
Harvard Medical School, Boston, MA
2021-2022 Sidney R. Baer, Jr. Foundation Fellow in the Clinical Neurosciences,
Berenson-Allen Center for Noninvasive Brain Stimulation, Beth Israel
Deaconess Medical Center, Harvard Medical School, Boston, MA
2021-2022 Norman E. Zinberg Fellow in Addiction Psychiatry Research, Department
of Psychiatry, Harvard University, Boston, MA
Licensure and Certification:
2017-2019 Massachusetts Limited Medical License
2019-2022 Massachusetts Medical License
2021 American Board of Psychiatry and Neurology
2022 Tennessee Medical License
Academic Appointments:
2021-2022 Clinical Fellow in Neurology, Harvard Medical School, Boston, MA
2022- Assistant Professor of Psychiatry and Behavioral Sciences, Clinician
Educator Track, Vanderbilt University School of Medicine, Nashville, TN
2023- Director, Research Track, Vanderbilt Psychiatry Residency Program
2024- Assistant Professor of Psychiatry and Behavioral Sciences,
Physician-Scientist Investigator Track (tenure-eligible)
Vanderbilt University School of Medicine, Nashville, TN
2024- Director of Neuromodulation Research, Department of Psychiatry and
Behavioral Sciences, Vanderbilt University Medical Center, Nashville, TN
Hospital Appointments:
2021-2022 Clinical Fellow in Neurology, Harvard Medical School, Boston, MA
2022- Psychiatrist, Vanderbilt Psychiatric Hospital, Nashville, TN
Professional Organizations
2020- Society of Biological Psychiatry
2020- Schizophrenia International Research Society
2020- College on Problems of Drug Dependence
2021- Clinical TMS Society
Professional Activities:
Hospital and Health Care Organization Service Responsibilities
2018-2021 Research Committee, Psychiatry Residency, Brigham & Women’s
Hospital, Harvard Medical School
2018-2021 Program Evaluation Committee, Psychiatry Residency, Brigham &
Women’s Hospital, Harvard Medical School
2018-2021 Residency Life Committee, Psychiatry Residency, Brigham & Women’s
Hospital, Harvard Medical School
2019-2021 Women in Psychiatry Founding Member, Psychiatry Residency,
Brigham & Women’s Hospital, Harvard Medical School
2020-2021 Chief Resident for Research, Department of Psychiatry,
Brigham & Women’s Hospital, Harvard Medical School, Boston, MA
2021-2022 Associate Director, Research Track, Psychiatry Residency,
Beth Israel Deaconess Medical Center, Harvard Medical School
2022- Faculty Advisor, Psychiatry Student Interest Group, Vanderbilt School of
Medicine
2023- Director, Research Track, Vanderbilt Psychiatry Residency
2023- Education Council, Department of Psychiatry, Vanderbilt University
Medical Center
2023- Grand Rounds Committee, Department of Psychiatry, Vanderbilt
University Medical Center
2023-2024 Chair, Academic Psychiatry Day Planning Committee, Department of
Psychiatry, Vanderbilt University Medical Center
Major Scientific Committee Assignments:
2019-2021 APA Council on Research, Fellow Member
2019-2021 APA Council on Addiction Psychiatry, Fellow Member
2019-2021 Research Committee, American Academy of Addiction Psychiatry (AAAP)
2021- Program Committee, College on Problems of Drug Dependence (CPDD)
2023- Physician Researcher Pipeline Task Force, Society of Biological Psychiatry
2023-2024 Program Committee, Schizophrenia International Research Society (SIRS)
2024- Mentor, College on Problems of Drug Dependence Mentorship Program
2024-2027 Program Committee, Society of Biological Psychiatry (SOBP)
Peer Review: Application and Grant Reviews
2020 National Center of Neuromodulation for Rehabilitation Pilot Grant,
Ad hoc reviewer, April 2020
2023- MSTP Mock Study Section, Vanderbilt University School of Medicine
2023- Limited Submission Opportunity Grant Review Committee, Vanderbilt
University Medical Center, Ad hoc reviewer
2024 Mechanistic Research on Neuromodulation for Substance Use Disorders
Treatment Special Emphasis Panel, National Institute on Drug Abuse:
Ad hoc reviewer, June 2024
2024 The Brain Foundation Netherlands, Ad hoc reviewer, July 2024
2024 Neural Basis of Psychopathology, Addictions, and Sleep Disorders (NPAS),
National Institutes of Health: Ad hoc reviewer, October 2024
Editorial Boards:
2019- Editorial Board Member, Harvard Review of Psychiatry
2022- Editorial Board Member, Frontiers in Psychiatry – Schizophrenia
Ad Hoc Reviewer: Addiction, Addiction Neuroscience, British Journal of Psychiatry, Drug and
Alcohol Dependence, European Archives of Psychiatry and Clinical Neuroscience, Imaging
Neuroscience, JAMA Network Open, Journal of Clinical Psychopharmacology, Nature Mental
Health, Neuropsychiatric Disease and Treatment, Neuropsychopharmacology, Neuroscience
Letters, Nicotine and Tobacco Research, PLOS One, Psychiatry Research, Psychotherapy and
Psychosomatics, SAGE Open Medical Case Reports, Schizophrenia, Schizophrenia Bulletin,
Schizophrenia Research, Substance Abuse Journal, Translational Psychiatry
Awards and Honors
2011 Morris & Gladys Lewy Scholarship
2011 Frederick C. Hagedorn, Jr. Class of 1971 Prize Scholarship
2014 DukeMed Engage Award
2016 Alpha Omega Alpha Honor Medical Society
2016 Chancellor’s Service Fellowship Award
2016 Albert Schweitzer Fellowship Award
2016 American Psychiatric Association Foundation Helping Hands Grant Award
2016 Senior Scholarship, Duke University School of Medicine
2017 Dean’s Recognition Award, Duke University School of Medicine
2019 American Psychiatric Association Leadership Fellowship
2019 Early Career Investigator Award, American Academy of Addiction Psychiatry
2020 APA Research Colloquium for Junior Psychiatrist Investigators
2021 Early Career Award, Schizophrenia International Research Society
2021 Early Career Award, College on Problems of Drug Dependence
2021 Harry C. and Maida Solomon Award, Harvard Medical School Department of
Psychiatry
2021 Honorable Mention, Early Career Research Presentation,
College on Problems of Drug Dependence
2021 Clinical and Translational Research Academy, Harvard Catalyst
2021 STAT News Wunderkind
2022 Neal Alan Mysell Award, Harvard Medical School Department of Psychiatry
Teaching Activities
Medical School Courses:
Duke University School of Medicine
2015-2016 Introduction to the Practice of Medicine, Small Group Leader, 10
students, 3 hours/week
2016-2017 Leadership Development, Curriculum Developer, Small Group Facilitator,
20 students, 6 hours/year
Vanderbilt University School of Medicine
2023-2024 Mood Disorders Lecture, 100 medical students, 3 hours/year
2023 Transition to Residency Workshop, 10 medical students, 1 hour/year
2023 Psychiatry Objective Structured Clinical Exam for VMS2s, 5 hours/year
2023 Psychiatry Physical Diagnosis Preceptor for VMS1s, 3 hours/year
2024- Psychotic Disorders Lecture, 100 medical students, 3 hours/year
Graduate Courses:
Harvard Medical School
2017-2021 Leadership Development Seminars, PGY-1-4 Psychiatry Residents,
7 hours/year.
2020 PGY-1 and PGY-2 Psychiatry Residents, Nicotine Dependence in Severe
Mental Illness: Pharmacotherapy & Psychotherapy, 2 hours/year.
Vanderbilt School of Medicine
2022-2024 Journal Club, Psychiatry Residency; Course Director, 9 hours/year.
2022- Introduction to Clinical & Research Applications of Repetitive Transcranial
Magnetic Stimulation Elective; Course Director, 20 hours/year.
2022- Pharmacologic and Psychotherapeutic Treatment of Nicotine Use
Disorder; Addiction Psychiatry & Addiction Medicine Fellowships,
Lecturer, 2 hours/year.
2023- Co-Occurring Substance Use and Psychotic Disorders; Addiction
Psychiatry & Addiction Medicine Fellowships, Lecturer, 2 hours/year.
2023- Neuromodulation for Substance Use Disorders; Addiction Psychiatry &
Addiction Medicine Fellowships, Lecturer, 2 hours/year.
2023 Psychiatry Objective Structured Clinical Exam for PGY-1s, 3 hours/year
2023- Research Didactics for Psychiatry Research Track Residents, 12
hours/year
Vanderbilt University
2023- Introduction to Clinical and Research Applications of Transcranial
Magnetic Stimulation; Principles of Pharmacology in Neuroscience,
Lecturer, 2 hours/year (Professor Dr. Christine Konradi)
2023- Clinical and Research Applications of Transcranial Magnetic Stimulation;
Neurobiology of Disease, Lecturer, 2 hours/year
(Professor Dr. Ariel Deutch)
2024- Pathophysiology and Treatment of Schizophrenia; Human Biology and
Disease, Lecturer, 3 hours/year (Professor Dr. Mark de Caestecker)
Continuing Medical Education Courses:
American Psychiatric Association
2021-2022 Leadership Training for Trainees by Trainees; Lecturer, 5 hours of
preparation
Community Courses:
Vanderbilt School of Medicine Program for High School Students Interested in Science
2022 Neuroscience & Society, Guest Lecturer, 20 students, 3 hours/year
Clinical Teaching:
2022-2023 Attending Psychiatrist, Inpatient Psychotic Disorders Unit, Vanderbilt Psychiatric
Hospital (1. Clinical Practice: inpatient psychiatric treatment; 2. Patient load:
10; 3. Clinical contributions: Providing supervision for PGY-1 and PGY-2
psychiatry residents, evaluating patients, writing inpatient attending notes)
2022- Attending Psychiatrist, Transcranial Magnetic Stimulation Service, Vanderbilt
Psychiatric Hospital (1. Clinical Practice: outpatient consultation and treatment
with TMS for refractory depression and obsessive-compulsive disorder; 2.
Patient load: 1; 3. Clinical contributions: Providing supervision for fellows,
evaluating patients, writing attending notes)
2022- Supervising Attending, Vanderbilt Psychiatric Hospital (Supervision of 1 adult
psychiatry resident, 1 hour/week)
2023- Attending Psychiatrist, Severe and Persistent Mental Illness Clinic, Vanderbilt
Psychiatric Hospital (1. Clinical Practice: outpatient psychiatric treatment; 2.
Clinical Load: 0.5 day clinic/week; 3. Clinical contributions: Providing supervision
for residents, evaluating patients, writing attending notes)
Trainees/Advisees:
Predoctoral Students
2019-2020 Yong (Daniel) Shen, Harvard University; medical student at
Columbia University Vagelos College of Physicians & Surgeons
2022- Ashwin Srinivasan, Washington University at St. Louis
2022- Daniel Bello, Vanderbilt University
2023- Sophia Blyth, Harvard University
2023- Geneghee Kim, Vanderbilt University
2023- Lena Kim, Vanderbilt University
2024- Brandon Sublett, Meharry Medical College
2024- Gabriela Torres Quesada, University of Texas at El Paso (Vanderbilt MSTP
Summer Program)
2024- Sean Yarrell, Vanderbilt University
Residents
2022- Julian Raffoul, MD, PGY-4 Vanderbilt University Medical Center; Addiction
Psychiatry Fellow, Vanderbilt University Medical Center
2022- Jordyn Chesley, MD, PGY-2 Vanderbilt University Medical Center
2023- Raza Sagarwala, MD, PGY-4 Vanderbilt University Medical Center
2023- Darara Borodge, MD, PGY-3 Vanderbilt University Medical Center
2023- Benjamin Johnson, MD, PGY-3 Vanderbilt University Medical Center
2023- Ross Masters, MD, PGY-2 Vanderbilt University Medical Center
2023- Claudia Cruz-Bosch, MD, PGY-2 Vanderbilt University Medical Center
Postdoctoral Fellows
2021-2022 Gulcan Yildiz, MD, Beth Israel Deaconess Medical Center; PGY-1
Vanderbilt University Medical Center
2022-2023 Timothy Adegoke, MD, MPH, Addiction Psychiatry & Neuromodulation
Fellow, Vanderbilt University Medical Center; Faculty Vanderbilt
Department of Psychiatry and Behavioral Sciences
Invited Lectures
2021 Harvard University, Brigham & Women’s Hospital and Harvard Medical
School Department of Psychiatry: Evidence for Schizophrenia-specific
Pathophysiology of Nicotine Dependence
2021 Harvard University, Mount Auburn Hospital Department of Psychiatry: A
Network-Based Approach to Nicotine Dependence in Schizophrenia
2021 Vanderbilt University, Department of Psychiatry: A Network-Based
Approach to Treatment of Substance Use Disorders in Schizophrenia
2021 Harvard University, Beth Israel Deaconess Medical Center, Berenson-
Allen Center for Noninvasive Brain Stimulation: Transcranial Magnetic
Stimulation for Smoking Cessation.
2021 Harvard University, Beth Israel Deaconess Medical Center, Berenson-
Allen Center for Noninvasive Brain Stimulation: Connectome-Wide
Analysis Identifies Treatment Targets for Cognitive Impairment in
Individuals at Clinical High Risk for Psychosis
2021 Harvard University, Beth Israel Deaconess Medical Center, Berenson-
Allen Center for Noninvasive Brain Stimulation: Evidence for
Schizophrenia-specific Pathophysiology of Nicotine Dependence
2022 Harvard University, Beth Israel Deaconess Medical Center: Network-
Targeted Neuromodulation for Nicotine Dependence
2023 Vanderbilt Department of Psychiatry Grand Rounds: Interventions for
Treatment-Resistant Depression When Pharmacotherapy Doesn’t Work
2023 University of Pennsylvania, Neuromodulation and Neuroimaging Relevant
to Affective Disorders Speaker Series, Center for Neuromodulation on
Depression and Stress: Network-Targeted Neuromodulation for Nicotine
Dependence
2023 Cognitive and Pharmacological Neuroimaging Unit, NIDA Intramural
Research Program: Network-Targeted Neuromodulation for Nicotine
Dependence
2024 Vanderbilt Center for Addiction Research Science Day: Use of Transcranial
Magnetic Stimulation to Probe Addiction Brain Circuitry
2024 Panelist, Physician-Scientist Residency Training Panel, Southeastern
Medical Scientist Symposium
2024 Mid-South Addiction Conference: Neuromodulation for Substance Use
Disorders
Research Program
Past Support
2017-2021 Research Track, Psychiatry Residency, Brigham & Women’s Hospital,
Harvard Medical School
2017-2021 Esther B Kahn Research Seed Grant
Brigham Care Redesign Incubator and Startup Program (BCRISP): Quality
and Financial Impact of Interdisciplinary Care Redesign for Behavioral
Health Boarding Patients in the Brigham & Women’s Faulkner Hospital
Emergency Department, Co-I: Heather Ward
2020-2021 COVID-19 Recovery & Reimagination Grant: A Prospective Observational
Study of Physician Burnout and Electronic Health Record Use During the
COVID-19 Pandemic, Co-PI: Heather Ward, Total Award: $5,750
2018-2021 Brigham Research Institute Micro Grant: Transcranial Magnetic
Stimulation to Reduce Craving in Individuals Taking Buprenorphine for
Opioid Use Disorder, Co-PI: Heather Ward, Total Award: $2,500
2021-2022 Sidney R. Baer, Jr. Foundation Fellowship: Circuit-Based Neuromodulation
of Nicotine Dependence in Psychotic Disorders, PI: Heather Ward, Total
Award $150,000
2021-2022 Harvard Medical School, Norman E. Zinberg Fellowship in Addiction
Psychiatry Research: A Circuit-Based Approach to Pathophysiology of
Nicotine Dependence in Psychotic Disorders, PI: Heather Ward, MD,
Total Award: $80,000
2021-2022 Harvard Medical School, Livingston Award, PI: Heather Ward, MD,
Total Award: $3,500
2023-2024 NCATS KL2TR002245: Network-Targeted Neuromodulation for Nicotine
Dependence, PI: Heather Ward, MD, Total Award: $150,000
Current Support
2021- NIDA Clinical Research Loan Repayment Program: Network-Targeted
Neuromodulation for Nicotine Dependence in Schizophrenia,
PI: Heather Ward, MD
2023-2025 Vanderbilt Kennedy Center Pilot Award: Accelerated DMN-Targeted rTMS
to Modulate DMN Connectivity
PI: Heather Ward, MD, Total Award: $27,000
2024-2029 NIDA K23DA059690: Network-Targeted Neuromodulation for Nicotine
Dependence in Schizophrenia,
PI: Heather Ward, MD, Total Award: $927,720
Publications and Presentations (Web of Science h-Index in July 2024 = 12)
Original Articles:
1. Cather C, Dyer M, Burrell HA, Hoeppner B, Goff DC, Evins AE. An Open Trial of Relapse
Prevention Therapy for Smokers with Schizophrenia. J Dual Diagnosis. 2013;9(1):87-93.
2. Burrell HA, Song K, Clements DA. A Qualitative Survey of Trash Disposal in Rural Honduran
Communities. Journal of Public Health in Developing Countries. 2016;2(3):291-296.
3. Ward HB, Szabo S, Rakesh G. Maintenance ECT in Schizophrenia: A Systematic Review.
Psychiatry Research. 2018; 264:131-142.
4. Otto MW, Pachas GN, Cather C, Hoeppner SS, Moshier SJ, Hearon BA, Ward HB, Laffer AB,
Smits JAJ, & Evins AE. A placebo-controlled randomized trial of d-cycloserine augmentation
of cue exposure therapy for smoking cessation. Cognitive Behavioural Therapy. 2019 Jan;
48(1): 65-76.
5. Ward HB*, Sakamoto JT*, Vissoci JRN, Eucker SA. Are non-pharmacologic pain interventions
effective at reducing pain in adult patients visiting the Emergency Department? A
Systematic Review and Meta-analysis. Academic Emergency Medicine. 2018; Mar 15. *Cofirst
authorship.
6. Ward HB, Fromson JA, Cooper JJ, De Oliveira G, Almeida M. Recommendations for the Use
of ECT in Pregnancy: Literature Review and Proposed Clinical Protocol. Archives of Women’s
Mental Health. 2018 Dec; 21(6): 715-722.
7. Ward HB, Barnett BS, Suzuki J. Rapid transition from methadone to buprenorphine using
naltrexone-induced withdrawal: A case report. Substance Abuse. 2019 Mar 19: 1-6.
8. Ward HB, Greenberg JA, & Almeida M. Perimenstrual Psychiatric Hospitalization: Case
Report and Literature Review. Archives of Women’s Mental Health. 2019 Jun 3.
9. Ward HB, Yudkoff BL, & Fromson JA. Lurasidone malabsorption following bariatric surgery:
a case report. Journal of Psychiatric Practice. 2019 Jul; 25(4): 313-317.
10. Ward HB & Almeida M. Lurasidone-Induced Mania: A Case Report. Primary Care Companion
– CNS Disorders. 2019 Jul 11; 21(4).
11. Ward HB, Lawson MT, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA,
Jeffries CD, Mathalon DH, McGlashan TH, Seidman LJ, Tsuang MT, Walker EF, Woods SW,
Perkins DO. Tobacco Use and Psychosis Risk in Persons at Clinical High Risk. Early
Intervention in Psychiatry. 2019 Oct; 13(5): 1173-1181.
12. Ward HB, Mosquera MJ, Suzuki J, & Mariano TY. A systematic review of noninvasive brain
stimulation for opioid use disorder. Neuromodulation. 2020 Apr; 23(3): 301-311.
13. Ward HB. Resident Physician Leadership in the Era of COVID-19: Harnessing Emotional
Intelligence. Academic Medicine. 2020 Oct;95(10):1521-1523.
14. Ward HB, Yip A, Siddiqui R, Morales OG, Seiner SJ, Siddiqi SH. Borderline personality traits
do not influence response to TMS. Journal of Affective Disorders. 2021 Feb; 281: 834-838.
15. Shen Y & Ward HB. Transcranial Magnetic Stimulation and Neuroimaging for Cocaine Use
Disorder: Review and Future Directions. American Journal of Drug and Alcohol Abuse. 2021
Mar; 47(2): 144-153.
16. Ward HB, Levin FR, Greenfield SF. Disparities in Gender and Race Among Physician
Scientists: A Call to Action and Strategic Recommendations. Academic Medicine. 2021 July
6.
17. Ward HB, Brady RO, Halko MA. Bridging the Gap: Strategies to Make Psychiatric
Neuroimaging Clinically-Relevant. Harvard Review of Psychiatry. 2021 May-Jun; 29(3): 185-
187.
18. Mosquera MJ, Ward HB, Holland C, Boland R, Torous J. Using Objective Clinical Metrics to
Understand the Relationship Between the Electronic Health Record and Physician Wellness:
An Observational Pilot Study. BJPsych Open. 2021 Sep 21; 7(5): e174.
19. Brady R, Ward HB, Lee I, Nielsen K, Nawaz U, Beermann A, Nye M, Xie J, Gonsalvez I, Eack S,
Ongur D, Keshavan M, Halko MA. Schizophrenia is Cerebellar-Cortical Circuit Dysfunction.
Under Review.
20. Ward HB, Brady RO, Halko MA, Lizano P. Noninvasive Brain Stimulation for Nicotine
Dependence in Schizophrenia: A Mini-Review. Frontiers in Psychiatry – Schizophrenia. 2022
Feb 9.
21. Ward HB, Beermann A, Nawaz U, Halko MA, Janes AC, Moran LV, Brady RO. Evidence for
Schizophrenia-specific Pathophysiology of Nicotine Dependence. Frontiers in Psychiatry –
Schizophrenia. 2022 Jan 27.
22. Ward HB, Nemeroff CB, Carpenter LL, Grzenda A, McDonald WM, Rodriguez CI, Kraguljac
NV. Substance Use Disorders in Schizophrenia: Prevalence, Etiology, Biomarkers, and
Treatment. Personalized Medicine in Psychiatry. 2023 May 17; 39(100106).
23. Patterson EM, Lim J, Fuchs P, Smith JR, Moussa-Tooks AB, Ward HB. Use of First-Generation
Antipsychotics in an Adolescent Male with Catatonic Schizophrenia. Harvard Review of
Psychiatry. 2023; 31(6): 267-273
24. Moussa-Tooks AB & Ward HB. Practical Recommendations to Improve Retention of
Underrepresented Minorities in Science and Medicine: An Early Career Perspective.
Neuropsychopharmacology. 2023 September 11. 48: 1837-1839.
25. Weyhaupt M, Hardcastle S, Jesse N, Almeida M, Ward HB. Diagnosis and Management of
Perimenstrual Cycloid Motility Psychosis. Harvard Review of Psychiatry. 2024 January 2.
32(1): 33-39.
26. Mehta D, Praecht A, Ward HB, Sanches M, Sorkou M, Tang VM, Steele VR, Hanlon CA,
George TP. A Systematic Review and Meta-Analysis of Neuromodulation Therapies for
Substance Use Disorders. Neuropsychopharmacology. 2023 December 12.
27. Moussa-Tooks AB, Beermann A, Manzanarez Felix K, Coleman MJ, Bouix S, Holt DJ,
Lewandowski KE, .ngür D, Breier A, Shenton ME, Heckers SH, Brady RO*, Ward HB*.
Isolation of Distinct Networks Driving Action and Cognition in Psychomotor Processes. In
Press, Biological Psychiatry. 2024 Mar 5. *Co-Last Authorship.
28. Feola B, Beermann A, Manzanarez Felix K, Coleman MJ, Bouix S, Holt DJ, Lewandowski KE,
.ngür D, Breier A, Shenton ME, Heckers SH, Brady RO, Blackford J, Ward HB. Data-Driven,
Connectome-Wide Analysis Identifies Psychosis-Specific Brain Correlates of Fear and
Anxiety. Molecular Psychiatry. 2024 Mar 19.
29. Blyth SH, Zabik NL, Krosche A, Prisciandaro JJ, Ward HB. rTMS for Co-occurring Psychiatric
and Substance Use Disorders: Narrative Review and Future Directions. In Press, Current
Addiction Reports.
30. Mehta D, Siddiqui S, Ward HB, Steele VR, Pearlson GD, George TP. Functional and Structural
Effects of Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of
Auditory Verbal Hallucinations in Schizophrenia: A Systematic Review of rTMSNeuroimaging
Studies. Schizophrenia Research. 2024 May; 267:86-98.
31. Adegoke T, Subramanian S, Daunis D, Bick S, Ward HB. A Case of Treatment-Resistant
Depression Complicated by Traumatic Brain Injury and Seizure: Implications for
Interventional Treatment and Psychiatric Training. Harvard Review of Psychiatry. 2024 May-
June 01;32(3):117-125.
32. Ward HB, Beermann A, Xie J, Yildiz G, Manzanarez Felix K, Addington J, Bearden CE,
Cadenhead K, Cannon TD, Cornblatt B, Keshavan M, Mathalon D, Perkins DO, Seidman L,
Stone WS, Tsuang MT, Walker EF, Woods S, Coleman MJ, Bouix S, Holt DJ, .ngür D, Breier A,
Shenton ME, Heckers SH, Halko MA, Lewandowski KE, Brady RO. Robust Brain Correlates of
Cognitive Performance in Psychosis and its Prodrome. In Press, Biological Psychiatry.
33. Ward HB*, Yassin W*, Bello D, Keedy S, Hill SK, Pearlson GD, Bishop J, Tamminga CA,
Sweeney J, Gershon ES, Clementz B, Brady RO, Keshavan MS. Associations Between History
of Cannabis and Alcohol Use Disorder and Brain Volume, Cognitive Performance, and
Symptoms in Psychotic Disorders. In Preparation. *Co-First Authorship.
34. Ward HB*, Lopez M*, Raymond N, Keedy S, Hill SK, Pearlson GD, Bishop J, Tamminga CA,
Sweeney J, Gershon ES, Clementz B, Keshavan MS, Lizano P. Associations of Polysubstance
Use with Brain Volume, Cognitive Performance, and Symptoms Across the Psychosis
Spectrum. In Preparation. *Co-First Authorship.
35. Bello D*, Jones M*, Artim L, Blyth SH, Brady RO, Vandekar S, Ward HB. Brain State and
Clinical Response to rTMS: Systematic Review and Meta-Analysis. In Revision. *Co-First
Authorship.
36. Blyth SH*, Cruz Bosch C*, Raffoul J, Chesley J, Johnson B, Borodge D, Sagarwala R, Masters
R, Brady RO, Vandekar S, Ward HB. Safety of rTMS for Schizophrenia: A Systematic Review
and Meta-Analysis. In Revision, Schizophrenia Bulletin. *Co-First Authorship.
37. Blyth SH, Polick C, Kim L, Eason S, Rubenstein D, Thompson S, Drummond T, Ward HB*,
Young J*. Noninvasive Brain Stimulation for Opioid Use Disorder: An Update of the
Literature. In Press, Current Behavioral Neuroscience Reports. *Co-Last Authorship.
38. Ward HB, Beermann A, Manzanarez Felix K, Narisetti L, Lewandowski KE, Brady RO, Moussa-
Tooks AB. Grip Strength as a Marker of Resting-State Network Integrity and Well-being in
Psychosis. Under Review.
39. Yarrell SA, Beermann A, Manzanarez Felix K, Coleman MJ, Bouix S, Holt D, Lewandowski KE,
.ngür D, Breier A, Shenton ME, Woodward N, Heckers S, Brady RO MD*, Ward HB*.
Cerebellar-Frontal Connectivity Predicts Negative Symptom Severity Across the Psychosis
Spectrum. In Preparation. *Co-Last Authorship.
40. Menon SN, Blyth SH, Torres Quesada G, Sublett B, Yarrell SA, Ward HB. A Systematic Review
of the Neural Mechanism of Neuromodulation for Substance Use Disorders. In Preparation.
41. Menon SN, Blyth SH, Torres Quesada G, Sublett B, Yarrell SA, Ward HB. Safety of TMS for
Substance Use Disorders: A Systematic Review and Meta-Analysis. In Preparation.
Books, book chapters, invited review articles, letters to editor, editorials:
1. Almeida M & Ward HB. Re: An Interesting Presentation About Cyclical Menstrual Psychosis
with an Updated Review of Literature. Psychopharmacol Bull. 2018; 48(4):8–9.
2. Ward HB & Almeida M. Re: A Case of Hypersexuality Probably Associated with Lurasidone.
In Press, Journal of Clinical Psychopharmacology. 12 Aug 2020.
3. Ward HB. A Brain-Circuit Approach to Treating Nicotine Dependence in Schizophrenia.
American Academy of Addiction Psychiatry Newsletter. 2021; 37(3): 7 & 17.
4. Ward HB, Fukuda A, Brown J, & Carpenter LL. Transcranial Magnetic Stimulation and Other
Neuromodulation Therapies. In Textbook of Psychopharmacology, Sixth Edition. Eds.
Nemeroff CB & Schatzberg AF. American Psychiatric Association 2022.
Presentations at Scientific Meetings:
Oral Presentations:
1. Are non-pharmacologic pain interventions effective at reducing pain in adult patients
visiting the Emergency Department? Oral Poster Presentation, American College of
Emergency Physicians Scientific Assembly, Las Vegas, NV.
2. Tobacco Use and Psychosis Risk in Persons at Clinical High Risk. International Congress on
Schizophrenia Research, San Diego, CA. May 2017.
3. Effect of Interdisciplinary Rounds on Length of Stay for Behavioral Health Patients in the
Emergency Department. Annual Meeting of the Academy of Consultation-Liaison Psychiatry,
San Diego, CA. November 2019.
4. Transcranial Magnetic Stimulation for Opioid Use Disorder: A Systematic Review & Protocol
for a Pilot Study. American Academy of Addiction Psychiatry Annual Meeting, San Diego, CA.
December 2019.
5. Evidence for Schizophrenia-specific Pathophysiology of Nicotine Dependence. APA Research
Colloquium for Junior Psychiatric Investigators. American College of
Neuropsychopharmacology Annual Meeting. December 2020.
6. Leadership Training for Trainees by Trainees. American Association of Directors of
Psychiatric Residency Training Annual Meeting, Virtual. March 2021.
7. Increasing Scholarly Activity by Residents Through a Chief Resident for Research. American
Psychiatric Association Annual Meeting, Virtual. May 2021.
8. Leadership Training for Trainees by Trainees. American Psychiatric Association Annual
Meeting, Virtual. May 2021. *Selected for APA Course of the Month in 2022.
9. So You Want to do Research? How to Develop a Research Curriculum for Trainees.
American Academy of Addiction Psychiatry Annual Meeting, Virtual. December 2021.
10. A Disease-Informed, Network-Targeted Neuromodulation Intervention Affects Craving in
Individuals with Schizophrenia and Nicotine Dependence. Data Blitz Presenter. American
College of Neuropsychopharmacology Annual Meeting, Phoenix, AZ. December 2022.
11. Defining and Engaging a Disease-Specific Target for Nicotine Use in Schizophrenia. Panel
Presenter. American College of Neuropsychopharmacology Annual Meeting, Tampa, FL.
December 2023.
12. Plugging the Leaky Pipeline: Bolstering Physician-Scientist Recruitment, Training, and
Retention in Psychiatric Research. Co-Chair. American College of Neuropsychopharmacology
Annual Meeting, Tampa, FL. December 2023.
13. A Schizophrenia-Specific, Network-Targeted Neuromodulation Intervention Affects Craving
in Individuals with Schizophrenia and Nicotine Dependence. Symposium. Society for
Research on Nicotine and Tobacco Annual Meeting, Edinburgh, Scotland. March 2024.
14. Defining and Engaging a Disease-Specific Target for Nicotine Use in Schizophrenia.
Symposium. Schizophrenia International Research Society Annual Meeting, Florence, Italy.
April 2024.
15. A Schizophrenia-Specific, Network-Targeted Neuromodulation Intervention Affects Craving
in Individuals with Schizophrenia and Nicotine Dependence. Symposium. College on
Problems of Drug Dependence Annual Meeting, Montreal, Canada. June 2024.
16. Smoke Signals: Decoding the Brain’s Response to Nicotine Cues. Chair, Oral Session. College
on Problems of Drug Dependence Annual Meeting, Montreal, Canada. June 2024.
Posters:
1. Effects of Varenicline and Nicotine Replacement Therapy on Cue-Induced Craving in
Recently-Abstinent Smokers. Poster Presentation. Society for Research on Nicotine and
Tobacco International Meeting, Boston, MA.
2. An Open Trial of Relapse Prevention Therapy for Smokers with Schizophrenia. Poster
Presentation. Society for Research on Nicotine and Tobacco International Meeting, Boston,
MA.
3. A Program Partnering Medical Students with ACT Teams to Improve Chronic Medical
Conditions in Patients with Severe Persistent Mental Illness. Poster Presentation. IPS: The
Mental Health Services Conference, New Orleans, LA.
4. Tobacco Use and Psychosis Risk in Persons at Clinical High Risk. Poster Presentation
American Psychiatric Association Annual Meeting, San Diego, CA.
5. A Program Partnering Medical Students with ACT Teams to Improve Chronic Medical
Conditions in Patients with Severe Persistent Mental Illness. Poster Presentation. American
Psychiatric Association Annual Meeting, San Diego, CA.
6. Recommendations for the Use of ECT in Pregnancy: Literature Review and Proposed Clinical
Protocol. Oral Poster Presentation, First Author. European Congress of Psychiatry Annual
Meeting, Warsaw, Poland.
7. ECT treats persistent cognitive deficits from autoimmune encephalitis. Poster Presentation.
International Society for ECT and Neurostimulation Annual Meeting, San Francisco, CA.
8. Borderline personality traits influence response to ECT but not to TMS. Poster Presentation.
International Society for ECT and Neurostimulation Annual Meeting, San Francisco, CA.
9. Evidence for Schizophrenia-specific Pathophysiology of Nicotine Dependence. Poster
Presentation. American College of Neuropsychopharmacology Annual Meeting, Virtual.
December 2020.
10. Evidence for Schizophrenia-specific Pathophysiology of Nicotine Dependence. Poster
Presentation. Schizophrenia International Research Society Annual Congress, Virtual. April
2021.
11. Evidence for Schizophrenia-specific Pathophysiology of Nicotine Dependence. Poster
Presentation. Harvard Psychiatry Research Day, Virtual. April 2021. *Winner, Solomon
Award for Best Resident Research Presentation.
12. Evidence for Schizophrenia-specific Pathophysiology of Nicotine Dependence. Poster
Presentation. Society for Biological Psychiatry Annual Meeting, Virtual. May 2021.
13. Evidence for Schizophrenia-specific Pathophysiology of Nicotine Dependence. Poster
Presentation. College on Drug Dependence Annual Meeting, Virtual. June 2021.
14. Evidence for Schizophrenia-specific Pathophysiology of Nicotine Dependence. Poster
Presentation. American College of Neuropsychopharmacology Annual Meeting, Virtual.
December 2021.
15. Connectome-Wide Analysis Identifies Treatment Targets for Cognitive Impairment in
Individuals at Clinical High Risk for Psychosis. Harvard Psychiatry Research Day, March 2022.
*Winner, Mysell Award for Best Fellow Research Presentation.
16. Connectomic Analysis Identifies a Network Target of Nicotine Dependence in Schizophrenia.
Society for Biological Psychiatry Annual Meeting. April 2022.
17. A Disease-Informed, Network-Targeted Neuromodulation Intervention Affects Craving in
Individuals with Schizophrenia and Nicotine Dependence. American College of
Neuropsychopharmacology Annual Meeting. December 2022. *Selected for Oral
Presentation
18. Disease-Informed Assessment Identifies Robust Brain Correlates of Cognitive Performance
in Psychosis and its Prodrome. Society for Biological Psychiatry Annual Meeting. April 2023.
19. A Disease-Informed, Network-Targeted Neuromodulation Intervention Affects Craving in
Individuals with Schizophrenia and Nicotine Dependence. Resting State Brain Connectivity
Meeting. September 2023.